“…Enhanced plaque formation by proteolytic enzymes has been reported for reoviruses by chymotrypsin, trypsin and papain [15,16], and pancreatin [4,19], vaccinia virus by trypsin and chymotrypsin [7,8], enteroviruses by pancreatin [20], influenza A and B viruses by pancreatin and trypsin [1], and parainfluenza virus type 3 [13] and type 4 [10] by trypsin. Spendlove and Schaffer [16] suggested that the enhanced plaque formation of reoviruses by proteolytic enzymes resulted from the action of the enzyme on a virus-associated substrate. Lerner et al [9], however, reported that trypsin treatment of reovirus type 2 or Coxsackie B5 had little or no effect on infectivity, but similar treatment of reovirus type 1 increased infectivity titers.…”